Anti-respiratory syncytial virus monoclonal antibodies show promise in the treatment and prophylaxis of viral disease.

AuthorsG Taylor, T Porter, S Dillon, J Trill, S Ganguly, T Hart, C Davis, P Wyde, P Tempest, W Harris
JournalBiochemical Society transactions (Biochem Soc Trans) Vol. 23 Issue 4 Pg. 1063-7 (Nov 1995) ISSN: 0300-5127 [Print] ENGLAND
PMID8654682 (Publication Type: Journal Article, Review)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Viral
  • Immunoglobulins, Intravenous
  • Animals
  • Antibodies, Monoclonal (adverse effects, pharmacology, therapeutic use)
  • Antibodies, Viral (adverse effects, pharmacology, therapeutic use)
  • Child
  • Genetic Engineering
  • Humans
  • Immunoglobulins, Intravenous (pharmacology, therapeutic use)
  • Respiratory Syncytial Virus Infections (immunology, prevention & control, therapy)
  • Respiratory Syncytial Viruses (immunology)
  • Safety

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: